Breaking NEWS: Vaccine-like injection touted as better than statins for “preventing” heart disease
(NaturalHealth365) We’ve reported on the dangers of statins many times on NaturalHealth365. From mood dysfunction to memory loss, the world’s top-selling drug – prescribed to lower blood cholesterol in the hopes of managing or preventing heart disease – comes with many questionable side effects. Now, doctors in the United Kingdom are rushing to test a new cholesterol-lowering drug – only this one is a pricey injection.
The new “heart jab” is supposed to work like a vaccine. It contains a drug called inclisiran, and the National Health Service (NHS) of Britain seems extremely hopeful about its potential impact on patients’ heart health. But is it safe long-term?
So-called “wonder jab” alleged to slash cholesterol levels is expensive and lacks support from long-term data
Inclisiran is from a class of drugs called PCSK9 inhibitors. PCSK9 inhibitors – including alirocumab (Praluent) and evolocumab (Repatha) – are very new to the British health market. They allegedly work by blocking the action of an enzyme called PCSK9; by inhibiting this enzyme, the liver can remove “lousy” LDL cholesterol from the blood more quickly.
Unlike alirocumab and evolocumab, however – which require a once or bi-monthly injection – inclisiran reportedly only needs to be injected once or twice per year. The drug works by turning off genes which normally make the PCSK9 enzyme. Reported side effects include back pain, aching muscles, diarrhea, headache, and fatigue.
Prior research on the drug revealed that inclisiran can decrease cholesterol by as much as 50 percent. Now, researchers, drug manufacturers, and the NHS seem so excited about this “wonder jab” that the NHS gave the green light for a new trial in Britain involving 40,000 middle-aged men and women who are taking statins and still have high cholesterol.
The very hopeful researchers claim that rolling out this drug onto the market could prevent as many as 55,000 heart attacks and strokes in the coming decade. Unfortunately, there are several valid points of contention with this new drug, and with the new trial that’s been shuttled so quickly down the pipeline:
- No one knows whether inclisiran and the other PCSK9 inhibitors are safe long-term.
- Inclisiran is about 100 times as expensive as statin drugs.
- The PCSK9 enzyme is involved in multiple bodily processes – and nobody yet knows what kind of widespread consequences there will be, if any, of shutting the enzyme down.
- Inclisiran does appear to reduce cholesterol levels – but there’s no proof it reduces the risk of heart disease.
- It’s not entirely clear that improving your cholesterol levels is the key to improving heart health anyway! Several recent papers provide evidence which challenges the long-held belief that high cholesterol is a risk factor for heart disease. In fact, the true culprit appears to be chronic inflammation – which is something that inclisiran doesn’t influence.
Prevent heart disease and improve your heart health with these 5 nutrients
Does the world really need another expensive drug, anyway? If you’re of the millions of people around the world diagnosed with or at risk for heart disease, then be sure you’re getting these five nutrients into your diet regularly:
As we’ve previously reported, these and other nutrients work synergistically to optimize heart health. Studies show that these nutrients (from both food and supplements) decrease many risk factors associated with heart disease, including systemic inflammation, endothelial dysfunction, heart failure, atherosclerosis, and high blood pressure.
So before asking your doctor about the latest and “greatest” drugs, try evaluating your plate, first – a move that many health experts are urging the public to do.
Sources for this article include: